🔬 Peritoneal cytology in PDAC is an independent prognostic factor and cytologic conversion after neoadjuvant therapy may unlock surgical candidacy. Are you performing washings? #PancreaticCancer#HPBSurgery#SurgicalOncology ➡️ https://t.co/wVwtnYlKBk
Neoadjuvant GOLP chemo regimen doubles event-free survival in resectable iCCA, 18 vs. 9 months. 🔬 Time to consider preop chemo in patients at high risk of recurrence. 🎯 #Cholangiocarcinoma#HPBSurgery ➡️ https://t.co/pR2pvyb8Ls
⚠️ Subtotal cholecystectomy: BDI rate just 0.3%, but bile leak 13.5% & ERCP needed in 16%. Pivoting strategy is surgical judgment, not defeat. ➡️ https://t.co/d3Z7glAJaz
#ASCO2026 is in 4 weeks (May 29–June 2, Chicago). For HPB surgeons, this meeting matters — 3 Phase III trials in liver, bile duct & pancreatic cancer. Can immunotherapy make the inoperable operable? ➡️ https://t.co/6hgiNV9PLJ
@TheNotoriousHPB Non-con CT for Kidney stones...sure. Free air...yeah you'll see it and call a surgeon who will order a contrasted CT. In our business--HPB surgery--non-con CT drastically decreases sensitivity and specificity but still helpful in unique clinical scenarios
💬 Viewpoint: Integration of #AI in medicine risks “never skilling” for trainees; deliberate design—such as commit-then-compare, AI coaching, and AI-free zones—is needed to support clinical expertise development.
https://t.co/HeXgOatLUW
Join us for our upcoming CGSO Videoconference: Gastric. Featuring live case presentations by CGSO Fellows from Roger Williams Medical Center and Roswell Park, with guest expert Dan Blazer III (Trey), MD, FACS.
Register now:
https://t.co/i9QcFTYT3y
🤖 Robotic cholecystectomy use in BMI ≥50 rose from 23%→56% (2020–2024), yet outcomes mirror laparoscopic across all BMI groups. Expertise > technology. 🏥 Patient selection still drives results. #HPBSurgery#RoboticSurgery#JACS ➡️ https://t.co/3XkHi1loNd
Honored to be at #PancreasClub2026 — cutting-edge science on pancreatic cysts, PDAC, and surgical innovation. This is where evidence meets practice. If you have pancreatic disease, this is the community fighting for you.
#HPBSurgery#PancreaticCancer#DDW2026
🙋♂️Has anyone incorporated drain CRP into their whipple post-op care pathway? I share my thoughts in a recent Annals of Surgical Oncology editorial ✍️ https://t.co/DmmmnZeEBm
You can read Dr. Baba’s study on using drain CRP here https://t.co/nQmfbytyIC
🤔Trying to wrap my head around this one.
🔥The word is out. It is spreading like wildfire among trainees🔥
OpenEvidence: OpenEvidence Creates the First AI in History to Score a Perfect 100% on the
USMLE https://t.co/zxQXjeNhhh
Nearly 1 in 4 cancer patients reported a disability. They faced higher costs, more transportation barriers, and worse health outcomes compared with nondisabled peers.
https://t.co/qkFNPal0E7
📈 “Textbook Outcomes” have been explored in liver and pancreas surgery helping us understand ideal outcomes 🏆 🥇
How do we use this in the real world? 🤔
Using Data to Inform Preoperative Discussions https://t.co/tWzjU9Klol